News

New chemical entity acotiamide hydrochloride hydrate that inhibits peripheral acetylcholinesterase activities was invented by Zeria. Acofide works by suppressing the degradation of acetylcholine that is believed to play

LIFEROL is a protein-based bio-replenishment product, which addresses the dual nature of immune metabolism: bioavailability of nutrients (immune-specific amino acids) and functional availability of immune revitalizers and minerals

Empagliflozin belongs to sodium glucose co-transporter-2 (SGLT2) inhibitor class of drugs, which blocks glucose re-absorption in the kidney and eliminates excess glucose through the urine. Boehringer Ingelheim metabolic-clinical

Phase 1 trial will assess the safety, pharmacokinetic and pharmacodynamic profile of BCX4161, a novel selective inhibitor of plasma kallikrein, in healthy volunteers. The study that is being

The research will focus on identifying and validating recurrent gene mutations that are potential targets for drug therapies. H3 Biomedicine president and CEO Markus Warmuth said genomic information

The multi-year research and development collaboration aims to apply gene therapy technology to modify a patient’s own T-cells genetically, known as chimeric antigen receptor (CAR) T-cells, to target

The larger facility located at 21 Finchdene Square, Toronto, increases the division’s footprint by 95,000ft² along with its capacity and capabilities. Bellwyck co-chief executive officer John Vella said,

CDI will receive $16m in funding to create three induced pluripotent stem cell (iPSC) lines for each of 3000 healthy and diseased donors, while Coriell Institute will get

Aubagio did not receive positive opinion from the committee concerning new active substance (NAS) designation. Genzyme CEO and president David Meeker said the positive CHMP opinion and broad